Measurement of pulmonary status and surfactant protein levels during dexamethasone treatment of neonatal respiratory distress syndrome
- PMID: 8984701
- PMCID: PMC472613
- DOI: 10.1136/thx.51.9.907
Measurement of pulmonary status and surfactant protein levels during dexamethasone treatment of neonatal respiratory distress syndrome
Abstract
Background: Early postnatal use of dexamethasone in infants with respiratory distress syndrome (RDS) has been shown effectively to improve pulmonary status and to allow early weaning off mechanical ventilation. However, the mechanisms to explain the beneficial effects of dexamethasone in ventilatory dependent preterm infants remain unclear.
Methods: A double blind, placebo controlled study was performed to determine the change in pulmonary ventilation of premature infants with RDS as a result of dexamethasone treatment, and to evaluate the effect of dexamethasone on the levels of surfactant-associated proteins A (SP-A) and D (SP-D) in the tracheal fluid from 34 premature infants with RDS and 29 control subjects.
Results: Dexamethasone treatment decreased fractional inspired oxygen concentration (FIO2), arterial carbon dioxide tension (PCO2), mean airway pressure (MAP), and facilitated successful weaning from mechanical ventilation. SP-A concentrations in the tracheal aspirates were increased at days 7 and 14, and SP-D concentrations were increased during the period from days 3 to 14 in the dexamethasone treated group compared with the control group. However, albumin levels in the tracheal aspirate samples were decreased after dexamethasone treatment over the period from days 3 to 14. There was an inverse correlation between PCO2 values and SP-A concentrations.
Conclusions: These results suggest that early use of dexamethasone can improve pulmonary status and also increase SP-A and SP-D levels in the tracheal fluid in premature infants with RDS.
Comment in
-
Steroids, surfactant and lung disease.Thorax. 1996 Sep;51(9):880-1. doi: 10.1136/thx.51.9.880. Thorax. 1996. PMID: 8984696 Free PMC article. No abstract available.
Similar articles
-
Surfactant protein A and saturated phosphatidylcholine in respiratory distress syndrome.Am J Respir Crit Care Med. 1994 Dec;150(6 Pt 1):1672-7. doi: 10.1164/ajrccm.150.6.7952631. Am J Respir Crit Care Med. 1994. PMID: 7952631
-
Surfactant apoprotein A (SP-A) in tracheal aspirates of newborn infants with RDS.Acta Paediatr Jpn. 1991 Oct;33(5):649-54. doi: 10.1111/j.1442-200x.1991.tb01880.x. Acta Paediatr Jpn. 1991. PMID: 1799120
-
Surfactant proteins and stable microbubbles in tracheal aspirates of infants with respiratory distress syndrome: relation to the degree of respiratory failure and response to exogenous surfactant.Eur J Pediatr. 1997 Feb;156(2):131-8. doi: 10.1007/s004310050571. Eur J Pediatr. 1997. PMID: 9039518
-
Choosing a right surfactant for respiratory distress syndrome treatment.Neonatology. 2009;95(1):1-5. doi: 10.1159/000151749. Epub 2008 Oct 2. Neonatology. 2009. PMID: 18832858 Review.
-
Inherited disorders of neonatal lung diseases.Turk J Pediatr. 2004 Apr-Jun;46(2):105-14. Turk J Pediatr. 2004. PMID: 15214737 Review.
Cited by
-
Circadian rhythm and the influence of physical activity on circulating surfactant protein D in early and long-standing rheumatoid arthritis.Rheumatol Int. 2011 Dec;31(12):1617-23. doi: 10.1007/s00296-010-1538-7. Epub 2010 May 29. Rheumatol Int. 2011. PMID: 20512337
-
Genetic disorders of surfactant dysfunction.Pediatr Dev Pathol. 2009 Jul-Aug;12(4):253-74. doi: 10.2350/09-01-0586.1. Pediatr Dev Pathol. 2009. PMID: 19220077 Free PMC article. Review.
-
Late (> 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.Cochrane Database Syst Rev. 2017 Oct 24;10(10):CD001145. doi: 10.1002/14651858.CD001145.pub4. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2021 Nov 11;11:CD001145. doi: 10.1002/14651858.CD001145.pub5. PMID: 29063594 Free PMC article. Updated.
-
Lung surfactant in a cystic fibrosis animal model: increased alveolar phospholipid pool size without altered composition and surface tension function in cftrm1HGU/m1HGU mice.Thorax. 1997 Aug;52(8):723-30. doi: 10.1136/thx.52.8.723. Thorax. 1997. PMID: 9337833 Free PMC article.
-
Early (< 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.Cochrane Database Syst Rev. 2017 Oct 24;10(10):CD001146. doi: 10.1002/14651858.CD001146.pub5. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2021 Oct 21;10:CD001146. doi: 10.1002/14651858.CD001146.pub6. PMID: 29063585 Free PMC article. Updated.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical